Citadel Advisors
ACHV icon

Citadel Advisors’s Achieve Life Sciences ACHV Stock Holding History

Citadel Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$596K Buy
202,800
+108,900
+116% +$484K ﹤0.01% 8864
2025
Q4 		$467K Buy
93,900
+69,700
+288% +$304K ﹤0.01% 9190
2025
Q3 		$76.2K Buy
+24,200
New +$66.4K ﹤0.01% 12002
2025
Q2 		– Sell
-11,800
Closed -$31.5K – 12317
2025
Q1 		$31.5K Buy
11,800
+7,600
+181% +$23.6K ﹤0.01% 12772
2024
Q4 		$14.8K Sell
4,200
-18,400
-81% -$83.4K ﹤0.01% 13391
2024
Q3 		$107K Sell
22,600
-42,400
-65% -$194K ﹤0.01% 11017
2024
Q2 		$306K Buy
65,000
+36,000
+124% +$173K ﹤0.01% 9098
2024
Q1 		$132K Buy
+29,000
New +$129K ﹤0.01% 10960
2023
Q4 		– Sell
-3,800
Closed -$16.3K – 14167
2023
Q3 		$16.3K Sell
3,800
-23,400
-86% -$118K ﹤0.01% 12781
2023
Q2 		$141K Sell
27,200
-8,700
-24% -$61K ﹤0.01% 10420
2023
Q1 		$244K Buy
35,900
+29,800
+489% +$142K ﹤0.01% 9808
2022
Q4 		$15.1K Buy
+6,100
New +$15.7K ﹤0.01% 13353
2022
Q3 		– Sell
-13,000
Closed -$63K – 12487
2022
Q2 		$63K Sell
13,000
-37,200
-74% -$252K ﹤0.01% 11774
2022
Q1 		$380K Buy
+50,200
New +$374K ﹤0.01% 10036

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's ACHV Position: Q3 2025 in Review

Citadel Advisors sold out of Achieve Life Sciences (ACHV) in Q3 2025, closing a stake of 24,718 shares — an estimated $67.8K sold.

Citadel Advisors first reported a position in ACHV in Q1 2015 and held it in 22 quarters. The position peaked at $149K in Q4 2021. 66 funds tracked by Wall St. Rank hold ACHV as of Q3 2025.

  • Citadel Advisors reported no remaining Achieve Life Sciences position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 24,718 Achieve Life Sciences shares in Q3 2025, an estimated $67.8K.
  • Citadel Advisors first reported a position in Achieve Life Sciences in Q1 2015 and held it in 22 quarters.
  • Citadel Advisors's Achieve Life Sciences position peaked at $149K in Q4 2021.
  • 66 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.